Found: 62
Select item for more details and to access through your institution.
Recommendations from the European Working Group for Value Assessment and Funding Processes in Rare Diseases (ORPH-VAL).
- Published in:
- 2017
- By:
- Publication type:
- journal article
A Comprehensive Characterization of Stemness in Cell Lines and Primary Cells of Pancreatic Ductal Adenocarcinoma.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 18, p. N.PAG, doi. 10.3390/ijms231810663
- By:
- Publication type:
- Article
The role of CXCR4 in highly malignant human gliomas biology: Current knowledge and future directions.
- Published in:
- Glia, 2014, v. 62, n. 7, p. 1015, doi. 10.1002/glia.22669
- By:
- Publication type:
- Article
Planning design of locally advanced pancreatic carcinoma using 4DCT and IMRT/IGRT technologies.
- Published in:
- Acta Oncologica, 2011, v. 50, n. 1, p. 72, doi. 10.3109/0284186X.2010.484425
- By:
- Publication type:
- Article
The Impact of CT-Assessed Liver Steatosis on Postoperative Complications After Pancreaticoduodenectomy for Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 11, p. 7063, doi. 10.1245/s10434-022-11946-x
- By:
- Publication type:
- Article
Evaluation of Minimal Important Difference and Responder Definition in the EORTC QLQ-PAN26 Module for Assessing Health-Related Quality of Life in Patients with Surgically Resected Pancreatic Adenocarcinoma.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 12, p. 7545, doi. 10.1245/s10434-021-09816-z
- By:
- Publication type:
- Article
Adjuvant PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) or Gemcitabine Followed by Chemoradiation in Pancreatic Cancer: A Randomized Phase II Trial.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2012, v. 19, n. 7, p. 2256, doi. 10.1245/s10434-011-2205-2
- By:
- Publication type:
- Article
Early intravenous administration of nutritional support (IVANS) in metastatic gastric cancer patients at nutritional risk, undergoing first-line chemotherapy: study protocol of a pragmatic, randomized, multicenter, clinical trial.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835919890281
- By:
- Publication type:
- Article
Randomized phase 2 study of valproic acid combined with simvastatin and gemcitabine/nab-paclitaxel-based regimens in untreated metastatic pancreatic adenocarcinoma patients: the VESPA trial study protocol.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12936-w
- By:
- Publication type:
- Article
CORRESPONDENCE.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2000, v. 92, n. 7, p. 574
- By:
- Publication type:
- Article
Immunomodulatory Effects of Endoscopic Ultrasound-Guided Thermal Ablation in Patients with Pancreatic Ductal Adenocarcinoma.
- Published in:
- Cancers, 2023, v. 15, n. 14, p. 3704, doi. 10.3390/cancers15143704
- By:
- Publication type:
- Article
Prediction of Early Distant Recurrence in Upfront Resectable Pancreatic Adenocarcinoma: A Multidisciplinary, Machine Learning-Based Approach.
- Published in:
- Cancers, 2021, v. 13, n. 19, p. 4938, doi. 10.3390/cancers13194938
- By:
- Publication type:
- Article
Efficacy of Endoscopic Ultrasound-Guided Ablation with the HybridTherm Probe in Locally Advanced or Borderline Resectable Pancreatic Cancer: A Phase II Randomized Controlled Trial.
- Published in:
- Cancers, 2021, v. 13, n. 18, p. 4512, doi. 10.3390/cancers13184512
- By:
- Publication type:
- Article
Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up of Exocrine Pancreatic Ductal Adenocarcinoma: Evidence Evaluation and Recommendations by the Italian Association of Medical Oncology (AIOM).
- Published in:
- Cancers, 2020, v. 12, n. 6, p. 1681, doi. 10.3390/cancers12061681
- By:
- Publication type:
- Article
ASO Visual Abstract: Very Early Recurrence After Curative Resection for Pancreatic Ductal Adenocarcinoma: Proof of Concept for a “Biologic R2 Definition”.
- Published in:
- 2024
- By:
- Publication type:
- Abstract
Very Early Recurrence After Curative Resection for Pancreatic Ductal Adenocarcinoma: Proof of Concept for a "Biological R2 Definition".
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2024, v. 31, n. 6, p. 4084, doi. 10.1245/s10434-024-15105-2
- By:
- Publication type:
- Article
Importance of complete staging in non-Hodgkin's lymphoma presenting as a cerebral mass lesion.
- Published in:
- 1996
- By:
- Publication type:
- journal article
Treatment sequences and prognostic/predictive factors in metastatic pancreatic ductal adenocarcinoma: univariate and multivariate analyses of a real-world study in Europe.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11377-1
- By:
- Publication type:
- Article
Prognosis of Upfront Surgery for Pancreatic Cancer: A Systematic Review and Meta-Analysis of Prospective Studies.
- Published in:
- Frontiers in Oncology, 2022, v. 11, p. 1, doi. 10.3389/fonc.2021.812102
- By:
- Publication type:
- Article
Pancreatic Enzyme Replacement Therapy in Patients Undergoing First-Line Gemcitabine Plus nab -paclitaxel for Advanced Pancreatic Adenocarcinoma.
- Published in:
- Frontiers in Oncology, 2021, v. 12, p. 1, doi. 10.3389/fonc.2021.688889
- By:
- Publication type:
- Article
Circulating Chromogranin A Is Cleaved Into Vasoregulatory Fragments in Patients With Pancreatic Ductal Adenocarcinoma.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.613582
- By:
- Publication type:
- Article
AVAREG: a phase 2, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastoma.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 9, p. 1304, doi. 10.1093/neuonc/now035
- By:
- Publication type:
- Article
Survival following adjuvant PCV or temozolomide for anaplastic astrocytoma.
- Published in:
- Neuro-Oncology, 2006, v. 8, n. 3, p. 253, doi. 10.1215/15228517-2006-005
- By:
- Publication type:
- Article
A multicenter retrospective study of chemotherapy for recurrent intracranial ependymal tumors in adults by the Gruppo Italiano Cooperativo di Neuro‐Oncologia.
- Published in:
- Cancer (0008543X), 2005, v. 104, n. 1, p. 143, doi. 10.1002/cncr.21110
- By:
- Publication type:
- Article
A multicenter study of the prognosis and treatment of adult brain ependymal tumors.
- Published in:
- Cancer (0008543X), 2004, v. 100, n. 6, p. 1221
- By:
- Publication type:
- Article
Brain metastases in locally advanced nonsmall cell lung carcinoma after multimodality treatment.
- Published in:
- Cancer (0008543X), 2002, v. 95, n. 3, p. 605, doi. 10.1002/cncr.10687
- By:
- Publication type:
- Article
Metastatic Site in Pancreatic Adenocarcinoma Correlates with Prognosis.
- Published in:
- JOP Journal of the Pancreas, 2012, v. 13, n. 5, Supp, p. 557
- By:
- Publication type:
- Article
Clinical and Translational Results of a Phase II Randomized Trial of Maintenance Sunitinib or Observation in Metastatic Pancreatic Adenocarcinoma.
- Published in:
- JOP Journal of the Pancreas, 2012, v. 13, n. 5, Supp, p. 551
- By:
- Publication type:
- Article
Salvage Therapy with Mitomycin and Ifosfamide in Patients with Gemcitabine-Resistant Metastatic Pancreatic Cancer: A Phase II Trial.
- Published in:
- Chemotherapy (0009-3157), 2011, v. 57, n. 2, p. 156, doi. 10.1159/000324865
- By:
- Publication type:
- Article
Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Phase 1B trial of Nab-paclitaxel plus gemcitabine, capecitabine, and cisplatin (PAXG regimen) in patients with unresectable or borderline resectable pancreatic adenocarcinoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Therapeutic management of refractory or relapsed primary central nervous system lymphomas.
- Published in:
- Annals of Hematology, 2001, v. 80, p. B113, doi. 10.1007/pl00022772
- By:
- Publication type:
- Article
Clinical outcomes and response to chemotherapy in a cohort of pancreatic cancer patients with germline variants of unknown significance (VUS) in BRCA1 and BRCA2 genes.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2023, v. 92, n. 6, p. 501, doi. 10.1007/s00280-023-04585-w
- By:
- Publication type:
- Article
Exploring chemotherapy holiday and drugs re-challenge in advanced pancreatic cancer patients.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Time to CA19-9 nadir: a clue for defining optimal treatment duration in patients with resectable pancreatic ductal adenocarcinoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Phase I dose-escalation study of milciclib in combination with gemcitabine in patients with refractory solid tumors.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase II trial of salvage therapy with trabectedin in metastatic pancreatic adenocarcinoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Hydroxyurea with or without imatinib in the treatment of recurrent or progressive meningiomas: a randomized phase II trial by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).
- Published in:
- 2016
- By:
- Publication type:
- journal article
A randomized phase II trial of two different 4-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel (PEXG or PDXG regimen).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 1, p. 115, doi. 10.1007/s00280-011-1680-2
- By:
- Publication type:
- Article
Outcome of upfront combination chemotherapy followed by chemoradiation for locally advanced pancreatic adenocarcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 6, p. 1253, doi. 10.1007/s00280-009-0995-8
- By:
- Publication type:
- Article
Prognostic factors in gemcitabine-cisplatin polychemotherapy regimens in pancreatic cancer: XPD-Lys751Gln polymorphism strikes back.
- Published in:
- International Journal of Cancer, 2013, v. 133, n. 4, p. 1016, doi. 10.1002/ijc.28078
- By:
- Publication type:
- Article
Effect of Diabetes on Survival after Resection of Pancreatic Adenocarcinoma. A Prospective, Observational Study.
- Published in:
- PLoS ONE, 2016, v. 11, n. 11, p. 1, doi. 10.1371/journal.pone.0166008
- By:
- Publication type:
- Article
Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R-IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high-dose methotrexate-based chemotherapy.
- Published in:
- Hematological Oncology, 2013, v. 31, n. 3, p. 143, doi. 10.1002/hon.2037
- By:
- Publication type:
- Article
Solitary clival plasmocytomas: Misleading clinical and radiological features of a rare pathology with a specific biological behaviour.
- Published in:
- Acta Neurochirurgica, 2013, v. 155, n. 10, p. 1849, doi. 10.1007/s00701-013-1845-3
- By:
- Publication type:
- Article
RNA Extraction from Endoscopic Ultrasound-Acquired Tissue of Pancreatic Cancer Is Feasible and Allows Investigation of Molecular Features.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 12, p. 2561, doi. 10.3390/cells9122561
- By:
- Publication type:
- Article
Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild-type KRAS advanced biliary tract cancer: A randomized phase 2 trial (Vecti-BIL study).
- Published in:
- 2016
- By:
- Publication type:
- journal article
The Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine (PEFG) Regimen in Advanced Biliary Tract Adenocarcinoma.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 9, p. 2208, doi. 10.1002/cncr.24970
- By:
- Publication type:
- Article
Carbohydrate Antigen 19-9 Change During Chemotherapy for Advanced Pancreatic Adenocarcinoma.
- Published in:
- Cancer (0008543X), 2009, v. 115, n. 12, p. 2630, doi. 10.1002/cncr.24302
- By:
- Publication type:
- Article
Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas.
- Published in:
- British Journal of Haematology, 2004, v. 126, n. 5, p. 657, doi. 10.1111/j.1365-2141.2004.05109.x
- By:
- Publication type:
- Article